Century Therapeutics Inc (IPSC) — Capital Reinvestment Ratio
Latest as of March 2022:
0.05x
Century Therapeutics Inc (IPSC) has a Capital Reinvestment Ratio of 0.05x as of March 2022, meaning it reinvests 0% of its operating cash flow ($86.75 Million) in capital expenditures ($4.07 Million). See free cash flow generation of Century Therapeutics Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.05x
Capex / Operating Cash Flow
Operating Cash Flow
$86.75 Million
USD
Capital Expenditures
$4.07 Million
USD
Data as of
Mar 2022
Most recent filing
Century Therapeutics Inc Capital Reinvestment Ratio (2015–2022)
This chart tracks Century Therapeutics Inc's Capital Reinvestment Ratio across 2 annual periods.
Annual Capital Reinvestment Ratio for Century Therapeutics Inc (2015–2022)
Year-by-year Capital Reinvestment Ratio for Century Therapeutics Inc from 2015 to 2022. For live market cap and broader valuation context, see Century Therapeutics Inc market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 2.18x | $14.05 Million | $30.60 Million | ▲ +672.7% |
| 2015 | 0.28x | $104.30 Million | $29.39 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow